SELLAS Life Sciences Group, Inc. Repayments of Long-Term Debt
SELLAS Life Sciences Group, Inc. (SLS) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2020-03-13
- SELLAS Life Sciences Group, Inc. repayments of long-term debt for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- SELLAS Life Sciences Group, Inc. repayments of long-term debt for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- SELLAS Life Sciences Group, Inc. repayments of long-term debt for the quarter ending 2019-06-30 was $0.00.
- SELLAS Life Sciences Group, Inc. repayments of long-term debt for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- SELLAS Life Sciences Group, Inc. repayments of long-term debt for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- SELLAS Life Sciences Group, Inc. repayments of long-term debt for fiscal 2018 was $7.60M, a 1506.98% increase from fiscal 2017.
- SELLAS Life Sciences Group, Inc. repayments of long-term debt for fiscal 2017 was $473.00K, a 91.52% decline from fiscal 2016.
- SELLAS Life Sciences Group, Inc. repayments of long-term debt for fiscal 2016 was $5.58M, a 42.65% increase from fiscal 2015.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 6 month as first filed | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 9 month as first filed | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $0.00 derived: sum of 2 quarters · filed 2020-03-13 | $0.00 derived: sum of 3 quarters · filed 2020-03-13 | $0.00 10-K · filed 2020-03-13 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | $76.00K derived: sum of 4 quarters · filed 2020-03-13 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | $76.00K derived: sum of 3 quarters · filed 2020-03-13 | $7.01M derived: sum of 4 quarters · filed 2020-03-13 | ||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 | $76.00K derived: sum of 2 quarters · filed 2020-03-13 | $7.01M derived: sum of 3 quarters · filed 2020-03-13 | $7.01M derived: sum of 4 quarters · filed 2020-03-13 | ||
| 2018-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $7.01M derived: sum of 2 quarters · filed 2020-03-13 | $7.01M derived: sum of 3 quarters · filed 2020-03-13 | $7.60M 10-K · filed 2020-03-13 | ||
| 2018-09-30 | $6.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $6.94M derived: sum of 2 quarters · filed 2019-11-14 | $7.53M 10-Q · filed 2019-11-14 | $7.64M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $589.00K 10-Q · filed 2019-08-14 | $709.00K derived: sum of 3 quarters · filed 2019-08-14 | $710.00K derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $589.00K 10-Q · filed 2019-05-15 | $709.00K derived: sum of 2 quarters · filed 2019-05-15 | $710.00K derived: sum of 3 quarters · filed 2019-05-15 | $1.06M derived: sum of 4 quarters · filed 2019-05-15 | ||
| 2017-12-31 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $121.00K derived: sum of 2 quarters · filed 2019-03-22 | $473.00K derived: sum of 3 quarters · filed 2019-03-22 | $473.00K 10-K · filed 2019-03-22 | ||
| 2017-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $353.00K derived: sum of 2 quarters · filed 2018-11-14 | $353.00K 10-Q · filed 2018-11-14 | $110.00K 10-Q · filed 2017-11-09 | $1.15M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $352.00K 10-Q · filed 2018-08-14 | $0.00 10-Q · filed 2017-08-14 | $1.15M derived: sum of 3 quarters · filed 2018-08-14 | $1.15M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-15 | $800.00K derived: sum of 2 quarters · filed 2018-05-15 | $800.00K derived: sum of 3 quarters · filed 2018-05-15 | $4.55M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $800.00K derived: sum of 2 quarters · filed 2017-11-09 | $4.55M derived: sum of 3 quarters · filed 2017-11-09 | $5.58M 10-K · filed 2017-03-15 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $3.75M derived: sum of 2 quarters · filed 2017-11-09 | $4.78M 10-Q · filed 2017-11-09 | $5.79M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | $3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $4.78M 10-Q · filed 2017-08-14 | $5.79M derived: sum of 3 quarters · filed 2017-08-14 | $6.78M derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | $1.03M 10-Q · filed 2017-05-10 | $2.04M derived: sum of 2 quarters · filed 2017-05-10 | $3.03M derived: sum of 3 quarters · filed 2017-05-10 | $3.99M derived: sum of 4 quarters · filed 2017-05-10 | ||
| 2015-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $2.00M derived: sum of 2 quarters · filed 2017-03-15 | $2.96M derived: sum of 3 quarters · filed 2017-03-15 | $3.91M 10-K · filed 2017-03-15 | ||
| 2015-09-30 | $988.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.96M derived: sum of 2 quarters · filed 2016-11-09 | $2.90M 10-Q · filed 2016-11-09 | $3.76M derived: sum of 4 quarters · filed 2017-03-15 | ||
| 2015-06-30 | $967.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.91M 10-Q · filed 2016-08-09 | $2.77M derived: sum of 3 quarters · filed 2017-03-15 | $3.67M derived: sum of 4 quarters · filed 2017-03-15 | ||
| 2015-03-31 | $947.00K 10-Q · filed 2016-05-10 | $1.80M derived: sum of 2 quarters · filed 2017-03-15 | $2.71M derived: sum of 3 quarters · filed 2017-03-15 | $2.71M derived: sum of 4 quarters · filed 2017-03-15 | ||
| 2014-12-31 | $858.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $1.76M derived: sum of 2 quarters · filed 2017-03-15 | $1.76M derived: sum of 3 quarters · filed 2017-03-15 | $1.77M 10-K · filed 2017-03-15 | ||
| 2014-09-30 | $901.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $905.00K derived: sum of 2 quarters · filed 2015-11-09 | $908.00K 10-Q · filed 2015-11-09 | |||
| 2014-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $7.00K 10-Q · filed 2015-08-06 | ||||
| 2014-03-31 | $3.00K 10-Q · filed 2015-05-07 | |||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |